All

International incidence of childhood cancer, 2001-10: a population-based registry study

Posted on by SGW Content
11
Feb
Eva Steliarova-Foucher 1, Murielle Colombet 2, Lynn A G Ries 3, Florencia Moreno 4, Anastasia Dolya 2, Freddie Bray 2, Peter Hesseling 5, Hee Young Shin 6, Charles A Stiller 7; IICC-3 contributors
Collaborators, Affiliations
PMID: 28410997
PMCID: PMC5461370
DOI: 10.1016/S1470-2045(17)30186-9

Erratum in

Correction to Lancet Oncol 2017; 18: 719-31.

[No authors listed]
Lancet Oncol. 2017 Jun;18(6):e301. doi: 10.1016/S1470-2045(17)30369-8.
PMID: 28593856  No abstract available.

Abstract

Background: Cancer is a major cause of death in children worldwide, and the recorded incidence tends to increase with time. Internationally comparable data on childhood cancer incidence in the past two decades are scarce. This study aimed to provide internationally comparable local data on the incidence of childhood cancer to promote research of causes and implementation of childhood cancer control.

Methods: This population-based registry study, devised by the International Agency for Research on Cancer in collaboration with the International Association of Cancer Registries, collected data on all malignancies and non-malignant neoplasms of the CNS diagnosed before age 20 years in populations covered by high-quality cancer registries with complete data for 2001-10. Incidence rates per million person-years for the 0-14 years and 0-19 years age groups were age-adjusted using the world standard population to provide age-standardised incidence rates (WSRs), using the age-specific incidence rates (ASR) for individual age groups (0-4 years, 5-9 years, 10-14 years, and 15-19 years). All rates were reported for 19 geographical areas or ethnicities by sex, age group, and cancer type. The regional WSRs for children aged 0-14 years were compared with comparable data obtained in the 1980s.

Findings: Of 532 invited cancer registries, 153 registries from 62 countries, departments, and territories met quality standards, and contributed data for the entire decade of 2001-10. 385 509 incident cases in children aged 0-19 years occurring in 2·64 billion person-years were included. The overall WSR was 140·6 per million person-years in children aged 0-14 years (based on 284 649 cases), and the most common cancers were leukaemia (WSR 46·4), followed by CNS tumours (WSR 28·2), and lymphomas (WSR 15·2). In children aged 15-19 years (based on 100 860 cases), the ASR was 185·3 per million person-years, the most common being lymphomas (ASR 41·8) and the group of epithelial tumours and melanoma (ASR 39·5). Incidence varied considerably between and within the described regions, and by cancer type, sex, age, and racial and ethnic group. Since the 1980s, the global WSR of registered cancers in children aged 0-14 years has increased from 124·0 (95% CI 123·3-124·7) to 140·6 (140·1-141·1) per million person-years.

Interpretation: This unique global source of childhood cancer incidence will be used for aetiological research and to inform public health policy, potentially contributing towards attaining several targets of the Sustainable Development Goals. The observed geographical, racial and ethnic, age, sex, and temporal variations require constant monitoring and research.

Funding: International Agency for Research on Cancer and the Union for International Cancer Control.

PubMed Disclaimer

Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Comment in

Similar articles

See all similar articles

Cited by

See all “Cited by” articles

References

  1. Parkin DM, Stiller CA, Draper GJ, Bieber CA, Terracini B, Young JL. International incidence of childhood cancer. International Agency for Research on Cancer; Lyon: 1988. – PubMed
  2. Parkin DM, Kramarova E, Draper GJ. International incidence of childhood cancer, volume 2. International Agency for Research on Cancer; Lyon: 1998.
  3. Ries LG, Smith MA, Gurney J. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program; Bethesda, MD: 1999. p. 179.
  4. Steliarova-Foucher E, Kaatsch P, Lacour B. Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:1915–1951. – PubMed
  5. Fritz A, Percy C, Jack A. International classification of diseases for oncology (ICD-O) 3rd edn. World Health Organization; Geneva: 2000.
  6. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103:1457–1467. – PubMed
  7. Segi M, Fujisaku S, Kurihara M, Narai Y, Sasajima K. The age-adjusted death rates for malignant neoplasms in some selected sites in 23 countries in 1954–1955 and their geographical correlation. Tohoku J Exp Med. 1960;72:91–103. – PubMed
  8. UN Department of Economic and Social Affairs Statistics division: methodology. Standard country or area codes for statistical use (M49) https://unstats.un.org/unsd/methodology/m49/ (accessed Oct 28, 2016).
  9. UN Department of Economic and Social Affairs Population division; world population prospects 2015. https://esa.un.org/unpd/wpp/ (accessed Jan 19, 2017).
  10. Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer. 1988;42:511–520. – PubMed
  11. Ducore JM, Parikh-Patel A, Gold EB. Cancer occurrence in southeast Asian children in California. J Pediatr Hematol Oncol. 2004;26:613–618. – PubMed
  12. Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet. 2012;3:268. – PMC – PubMed
  13. Magrath I, Steliarova-Foucher E, Epelman S. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14:e104–e116. – PubMed
  14. Ospina-Romero M, Portilla CA, Bravo LE, Ramirez O. Caregivers’ self-reported absence of social support networks is related to treatment abandonment in children with cancer. Pediatr Blood Cancer. 2016;63:825–831. – PubMed
  15. Steliarova-Foucher E, Stiller C, Colombet M, Kaatsch P, Zanetti R, Peris-Bonet R. Registration of childhood cancer: moving towards pan-European coverage? Eur J Cancer. 2015;51:1064–1079. – PubMed
  16. Mahoney MC, Va P, Stevens A, Kahn AR, Michalek AM. Fifty years of cancer in an American Indian population. Cancer. 2009;115:419–427. – PubMed
  17. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605–613. – PubMed
  18. Stefan DC, Stones DK, Wainwright RD. Childhood cancer incidence in South Africa, 1987–2007. S Afr Med J. 2015;105:939–947. – PubMed
  19. Mutyaba I, Phipps W, Krantz EM. A population-level evaluation of the effect of antiretroviral therapy on cancer incidence in Kyadondo County, Uganda, 1999–2008. J Acquir Immune Defic Syndr. 2015;69:481–486. – PMC – PubMed
  20. Wabinga HR, Nambooze S, Amulen PM, Okello C, Mbus L, Parkin DM. Trends in the incidence of cancer in Kampala, Uganda 1991–2010. Int J Cancer. 2014;135:432–439. – PubMed
  21. Togo B, Traore F, Togo AP. Epidemiology and prognosis of childhood cancers at Gabriel-Toure Teaching Hospital (Bamako, Mali) Med Sante Trop. 2014;24:68–72. (in French). – PubMed
  22. Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and Hispanic groups by state and place: 2007–2011. United Stated Census Bureau; Washington, DC: 2013.
  23. Walsh KM, Chokkalingam AP, Hsu LI. Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children. Leukemia. 2013;27:2416–2419. – PMC – PubMed
  24. Gupta A. Pesticide use in south and south-east Asia: environmental public health and legal concerns. Am J Environ Sci. 2012;8:152.
  25. Ward MH, Colt JS, Metayer C. Residential exposure to polychlorinated biphenyls and organochlorine pesticides and risk of childhood leukemia. Environ Health Perspect. 2009;117:1007–1013. – PMC – PubMed
  26. Hernandez AF, Menendez P. linking pesticide exposure with pediatric leukemia: potential underlying mechanisms. Int J Mol Sci. 2016;17:461. – PMC – PubMed
  27. Horesh N, Horowitz NA. Does gender matter in non-Hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J. 2014;5:e0038. – PMC – PubMed
  28. Stiller CA, Parkin DM. International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol. 1990;4:303–324. – PubMed
  29. Levine AM. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst. 1993;85:1382–1397. – PubMed
  30. van den Bosch CA. Is endemic Burkitt’s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol. 2004;5:738–746. – PubMed
  31. Mutalima N, Molyneux E, Jaffe H. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One. 2008;3:e2505. – PMC – PubMed
  32. Koh YW, Kang HJ, Yoon DH. Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea. Ann Hematol. 2013;92:1653–1660. – PubMed
  33. Hjalgrim H. On the aetiology of Hodgkin lymphoma. Dan Med J. 2012;59:B4485. – PubMed
  34. Amayiri N, Bouffet E. Pediatric neuro-oncology. In: Stefan DC, Rodriguez-Galindo C, editors. Pediatric neuro-oncology in countries with limited resources: a practical manual. Springer Science & Business Media; New York: 2014. pp. 365–376.
  35. Hadley LG, Rouma BS, Saad-Eldin Y. Challenge of pediatric oncology in Africa. Semin Pediatr Surg. 2012;21:136–141. – PubMed
  36. Reutfors J, Kramarova E, Weiderpass E, Monge P, Wesseling C, Ahlbom A. Central nervous system tumours in children in Costa Rica, 1981–96. Paediatr Perinat Epidemiol. 2002;16:219–225. – PubMed
SGW Content

Leave a Reply

Your email address will not be published. Required fields are marked *